Founded

Address

Lilly Ventures
115 W. Washington Street
South Tower 1680
Indianapolis, IN 46204
United States

Open map


Recent investment activity

KANDO id: 30096

Corporate information

Registration country

Funding rounds

Top investment portfolio themes

Actual initial investment stage
N/A (1)

Investment activity status
Active investor

Selected investments

Displaying 1 - 25 of 36
Profile Country Date Funding
Bayhill Therapeutics A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases. N/A
Cabrellis Pharmaceuticals Corp Development of important therapies for the treatment of cancer Series A
Cerulean Pharma Inc Series D
Cerulean Pharma Inc Series C
CGI Pharmaceuticals Inc A biopharmaceutical company developing small molecule therapeutics for multiple oncology and immunology-based indications. N/A
Conforma Therapeutics Corp Novel drugs company for the selective treatment of cancer. N/A
Forma Therapeutics Inc N/A
GlobeImmune Inc Biopharmaceuticals company. N/A
Hydra Biosciences Inc N/A
InCube Ventures LLC Life science venture capital firm focused on investing in extraordinary innovations that solve unmet clinical needs for large patient populations. N/A
Intradigm Corp N/A
IRX Therapeutics Inc N/A
Kanisa Pharmaceuticals Inc Biopharmaceutical company employing a targeted approach to the diagnosis and treatment of cancer. N/A
Nimbus Discovery LLC A computational technology-based drug discovery company. Series A
Receptos Inc [] Series A
RelayHealth Corp N/A
Remon Medical Technologies Inc Medical device company providing smart, miniature implants. Series C
Serenex Inc Oncology-focused drug development company N/A
Sutro Biopharma Inc Series C
Viamet Pharmaceuticals Inc N/A
Aileron Therapeutics Inc Developing a breakthrough proprietary peptide technology platform N/A
Anthera Pharmaceuticals Inc N/A
Avid Radiopharmaceuticals Inc Series D
Avid Radiopharmaceuticals Inc Series C
Avid Radiopharmaceuticals Inc Series A

Past employees

Selected Products / Customers

Financials